Top Markets
Coin of the day
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Clasificación en acciones #26169
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Precio por acción
$1.73
Capitalización bursátil
$42.88M
Cambio (1 día)
2.16%
Cambio (1 año)
-18.85%
País
PL
Comercio Molecure S.A. (MOC)

Categoría

Historial del precio de la acción de Molecure S.A. (MOC)
Precio más alto de cierre: $1.72 el 2026-08-01

Precio más bajo de cierre: $8.01 el 2018-04-01
Historial del precio de la acción de Molecure S.A. desde 2018 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -4.92%
2025 -23.76%
2024 -51.57%
2023 52.92%
2022 -63.44%
2021 -31.76%
2020 420.16%
2019 -41.51%
2018 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$539.96 36.92%
US
$1.03K 56.34%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$133.41 396.11%
US